Irving Investors
Denver, Coloradoirvinginvestors.com
Overview
Irving Investors is a growth fund with a sector agnostic approach . The firm was founded in 2009 and has since expanded into credit and private investments . The fund seeks to form meaningful relationships with companies by offering its capital, expertise and connections to promote growth and return on investment . Irving has been involved in several successful private exits and is a trusted advisor and LP in Venture Capital funds .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Snyk | Dec 2022 | Series G | Co-investor |
| Metagenomi | Jan 2022 | Series B | Co-investor |
| DNA Script | Jan 2022 | Series C | Lead |
| Model Medicines | Nov 2021 | Series A | Co-investor |
| Shoreline Biosciences | Nov 2021 | Series B | Co-investor |
Key People
Christopher Chism
COO
Jeremy Abelson
Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
